ncRNA name
HOXA11-AS
Specific or universal ncRNAs
Universal ncRNAs
Class
Long noncoding RNA
Biomarker
None
Biomarker application
Upstream regulatory factors
Not available
Downstream target
microRNA-98/PBX3
Cancer name
Nasopharyngeal Carcinoma
Cancer site
qRT-PCR,Western blot
Treatment type
Chemotherapy
Drug
Cisplatin
Impact of wild-type ncRNA on chemotherapy resistance
Up
Impact of knockdown of ncRNA on chemotherapy resistance
Impact of overexpression of ncRNA on chemotherapy resistance
ncRNA differential expression in
cancer
patients vs. healthy people
Not available
Number of patients
Not available
Male patients
Not available
Female patients
Not available
Age range and number
Not available
PMID
Description
HOXA11-AS induces cisplatin resistance by modulating the microRNA-98/PBX3 axis in nasopharyngeal carcinoma
Tissue resource
nasopharyngeal carcinoma tissues and adjacent normal tissues
human normal nasopharyngeal epithelial cell lines NP-69
human nasopharyngeal carcinoma cell lines 5–8F
human nasopharyngeal carcinoma cell lines SUNE1
Experiment
None
Institute
the Shanghai Ninth People's Hospital
BeNa Culture Collection
Country
China
China
Continent
Asia
Asia